GSK Investigational Site — New York, New York

GSK Investigational Site is a clinical research site located in New York, New York, United States NY 10021.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 405 clinical trials with 47 currently active.

Therapeutic areas: Amyotrophic Lateral Sclerosis, Neoplasms, Hypertrophy, Left Ventricular.

Sponsors: GlaxoSmithKline, Tesaro, Inc., ViiV Healthcare.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 405 clinical trials on record, with 47 currently active. Their work covers Amyotrophic Lateral Sclerosis, Neoplasms, Hypertrophy, Left Ventricular.

Is GSK Investigational Site accredited by Crixeo Health?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.